In a 68- and 72-week clinical trial studying Wegovy (2.4 mg), brand-name Semaglutide, and Zepbound (15 mg), brand-name Tirzepatide, in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20% respectively, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
According to allegations raised in a recently filed product liability lawsuit, Novo Nordisk has failed to adequately warn consumers and the medical community about the risk of severe Ozempic side effects, which could cause users of the diabetes and weight loss drug to experience severe stomach paralysis from delayed gastric emptying
We encourage you to discuss your complete medical history with Dr
Most side effects are: Mild to moderate in severity Digestive in nature (nausea, constipation, or diarrhea) Temporary, resolving within days to weeks Manageable with proper dosing and supportive strategies Serious side effects are rare but can include pancreatitis, gallbladder issues, or allergic reactions
This personalized approach helps maximize the benefits of skinny shots while supporting your long-term weight management success
Hopkins (eds.)
